Pfizer Inc. Profile Avatar - Palmy Investing

Pfizer Inc.

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin f…
Drug Manufacturers - General
US, New York [HQ]
PFE/Financial Reporting

Income Statements

15 Sheets · Starting from 2023
In Million USD. Margins, Growth Rates In %
Metric 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Revenue
50,009.00 67,809.00 67,425.00 58,986.00 51,584.00 49,605.00 48,851.00 52,824.00 52,546.00 53,647.00 51,750.00 41,908.00 81,288.00 100,330.00 58,496.00
EPS
1.23 1.03 1.28 1.96 3.23 1.44 1.13 1.18 3.57 1.90 2.92 1.26 3.95 5.59 0.38
Profit
41,121.00 51,530.00 52,340.00 47,652.00 41,998.00 40,028.00 39,203.00 40,495.00 41,306.00 42,399.00 41,531.00 33,216.00 50,467.00 65,986.00 29,283.00
Pre Tax
10,827.00 9,422.00 12,762.00 12,080.00 15,716.00 12,240.00 8,965.00 8,351.00 12,305.00 11,885.00 17,682.00 7,497.00 24,311.00 34,729.00 1,058.00
ETR
15.19 11.93 31.52 21.21 27.40 25.49 22.20 13.45 -73.54 5.94 7.83 6.36 7.62 9.58 -105.29
Net
8,635.00 8,257.00 10,009.00 14,570.00 22,003.00 9,135.00 6,960.00 7,215.00 21,308.00 11,153.00 16,273.00 7,020.00 21,979.00 31,372.00 2,119.00
EBITDA
22,514.00 23,047.00 29,173.00 25,046.00 21,926.00 19,231.00 17,693.00 19,076.00 20,237.00 21,412.00 19,747.00 14,066.00 28,533.00 43,639.00 10,525.00
Operating Income
15,651.00 14,158.00 18,175.00 17,991.00 16,366.00 13,499.00 12,976.00 13,730.00 14,107.00 15,045.00 15,137.00 10,630.00 24,833.00 40,030.00 4,235.00
Interest Income
746.00 402.00 458.00 383.00 403.00 425.00 471.00 470.00 391.00 333.00 226.00 73.00 36.00 251.00 1,624.00
Loss
-34,777.00 -53,651.00 -49,250.00 -40,995.00 -35,218.00 -36,106.00 -35,875.00 -39,094.00 -38,439.00 -38,602.00 -37,829.00 -33,148.00 -61,053.00 -63,058.00 -54,261.00
Cost of Revenue
-8,888.00 -16,279.00 -15,085.00 -11,334.00 -9,586.00 -9,577.00 -9,648.00 -12,329.00 -11,240.00 -11,248.00 -10,219.00 -8,692.00 -30,821.00 -34,344.00 -29,213.00
Operating Expenses
-25,889.00 -37,372.00 -34,165.00 -29,661.00 -25,632.00 -26,529.00 -26,227.00 -26,765.00 -27,199.00 -27,354.00 -27,610.00 -24,456.00 -30,232.00 -28,714.00 -25,048.00
Depreciation and Amortization
-4,757.00 -8,487.00 -9,026.00 -7,611.00 -6,410.00 -5,537.00 -5,157.00 -5,757.00 -6,269.00 -6,384.00 -6,010.00 -4,777.00 -5,191.00 -5,064.00 -6,290.00
Interest Expenses
-1,233.00 -1,799.00 -1,681.00 -1,524.00 -1,414.00 -1,360.00 -1,199.00 -1,186.00 -1,270.00 -1,316.00 -1,574.00 -1,449.00 -1,291.00 -1,238.00 -2,369.00
Other Expenses
-4,405.00 -3,339.00 -5,413.00 -5,911.00 -361.00 -325.00 -3,282.00 -4,663.00 -923.00 -2,178.00 -2,545.00 -3,133.00 -522.00 -5,301.00 -3,177.00
WA Shares Outstanding
7,007.00 8,036.00 7,817.00 7,442.00 6,813.00 6,346.00 6,176.00 6,089.00 5,970.00 5,872.00 5,569.00 5,555.00 5,601.00 5,608.00 5,643.00
End of PFE's Analysis
CIK: 78003 CUSIP: 717081103 ISIN: US7170811035 LEI: - UEI: MHBQULRMEEJ5
Secondary Listings